Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
ADC Therapeutics SA (NYSE: ADCT)
ADCT Stock Predictions and Ratings
WSX Rating:
SELL
WSX Forecast (1yr):
-4.60%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
159.70%
ADCT Stock Analysis
ADCT
PE Ratio:
ADCT
PEG Ratio:
Not Available
ADCT
Forward EPS Growth (12 month):
0.00%
ADCT
PS Ratio:
4.9
ADCT
PSG Ratio:
Not Available
ADCT
Forward Revenue Growth (12 month):
0.00%
ADCT Articles
No data was found